01
CAR-T Cell Therapy
Advanced genetically engineered immune treatment for refractory hematologic malignancies.
Advanced Hematologic Care
Hematology Institute
Comprehensive, patient-centered care for malignant and benign hematologic diseases — integrating advanced therapies, clinical innovation, and multidisciplinary support.
CAR-T Therapy
Clinical Innovation
Multidisciplinary Care
Overview
At a Glance
A leading hematology center combining clinical excellence, cutting-edge therapies, and an active research portfolio — all delivered with compassion and continuity of care.
1,200+ Patients Annually
Treated through over 20,000 inpatient, day-care, and outpatient clinical visits each year.
Dozens of Clinical Trials
Active research in malignant hematology and coagulation disorders, expanding treatment options.
CAR-T Program (Since 2022)
Cutting-edge personalized immunotherapy for refractory hematologic malignancies.
Multidisciplinary Care
Integrated medical, nursing, psychological, social and spiritual care for patients and families.
Our Vision
To deliver world-class treatment alongside groundbreaking research that improves outcomes and quality of life for every patient with a hematologic disease.
Focus
Areas of Excellence
Malignant Hematology
Comprehensive treatment of leukemias, lymphomas, and myeloma.
Benign Hematology
Care for anemias, bleeding disorders, and coagulation conditions.
Cellular Therapy
CAR-T and advanced immunotherapy for refractory disease.
Translational Research
Bridging laboratory discovery and bedside clinical practice.
Programs
Services & Programs
02
Comprehensive Molecular Diagnostics
State-of-the-art hematology laboratory performing immunophenotyping, coagulation studies, and advanced genetic testing.
03
HLH Research Program
Nationally leading research initiative studying inflammatory complications associated with blood cancers.
04
Multidisciplinary Care Model
Integrated medical, nursing, psychological, social work, and spiritual care services supporting patients and families throughout treatment.
05
Active Clinical Trials
Dozens of trials in malignant hematology and coagulation disorders, offering patients access to emerging therapies.
06
Day-Care & Outpatient Services
Over 20,000 visits each year through inpatient, day-care, and outpatient clinics.
Leadership
Dr. Gilad Itchaki
Director of the Hematology Institute
Specialist in CLL and lymphomas. Trained at Rabin Medical Center and completed a two-year fellowship at the Dana-Farber Cancer Institute / Harvard Medical School. Active researcher, lecturer at Tel Aviv University, and a member of national and international hematology groups.
“Hematology is a discipline that excels at integrating breakthrough technologies and translating them into standard clinical practice, while uniquely combining innovation and professional excellence with humanity and compassion in patient care.”
Interested in partnering with this center?
Let's discuss how the Hematology Institute at Meir Medical Center can collaborate with you.